- According to estimates from 15 analysts, Dyne Therapeutics, Inc. stock's average price target has risen from $39.33 to $39.53, with forecasts ranging from $17 to $50 per share
- Based on the Jul. 29 closing price, the updated target implies approximately 58% potential upside
- Consensus rating remains at “Buy” across 17 covering analysts, with 16 Buys, 1 Holds and 0 Sells
Explore more price target data and ratings for Dyne Therapeutics, Inc. on the , and track all previous and future analyst recommendations for Dyne Therapeutics, Inc. in the dedicated .
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.